Frequently Asked Questions
The market is segmented based on , By Drug Class (Polycyclic aromatic hydrocarbon (PAH), Prostacyclin Analogs, Others), Demographic (Adult, Geriatric), Application (Pulmonary Arterial Hypertension, Systemic Sclerosis, Others), Dosage Form (Solution, Other), Route of Administration (Intravenous, Inhalation), End-Users (Clinic, Hospital, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy) – Industry Trends and Forecast to 2030.
.
The Global Iloprost Market size was valued at USD 106.17 USD Million in 2022.
The Global Iloprost Market is projected to grow at a CAGR of 11.5% during the forecast period of 2023 to 2030.
The major players operating in the market include Bayer AG, Vectura Group plc, VisionGate , Janssen Global Services LLC, TransoPharm Handels GmbH, LGM Pharma, Newchem, YONSUNG Fine Chemicals Co. .
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E., Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.
